CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3297
+0.0111 (3.48%)
At close: Aug 14, 2026, 4:00 PM EDT
0.3394
+0.0097 (2.94%)
After-hours: Aug 14, 2026, 7:57 PM EDT
CollPlant Biotechnologies Revenue
CollPlant Biotechnologies had revenue of $73.00K in the quarter ending March 31, 2026, a decrease of -96.45%. This brings the company's revenue in the last twelve months to $389.00K, down -84.26% year-over-year. In the year 2025, CollPlant Biotechnologies had annual revenue of $2.37M with 360.39% growth.
Revenue (ttm)
$389.00K
Revenue Growth
-84.26%
P/S Ratio
16.03
Revenue / Employee
$9,974
Employees
39
Market Cap
6.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.37M | 1.86M | 360.39% |
| Dec 31, 2024 | 515.00K | -10.44M | -95.30% |
| Dec 31, 2023 | 10.96M | 10.66M | 3,565.22% |
| Dec 31, 2022 | 299.00K | -15.34M | -98.09% |
| Dec 31, 2021 | 15.64M | 9.50M | 154.86% |
| Dec 31, 2020 | 6.14M | 3.82M | 164.75% |
| Dec 31, 2019 | 2.32M | -2.70M | -53.77% |
| Dec 31, 2018 | 5.01M | 4.55M | 982.94% |
| Dec 31, 2017 | 463.00K | 387.12K | 510.15% |
| Dec 31, 2016 | 75.88K | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bolt Biotherapeutics | 4.70M |
| BioAtla | 2.00M |
| BioRestorative Therapies | 357.87K |
| Addex Therapeutics | 136.51K |
| Cardio Diagnostics Holdings | 14.45K |
CLGN News
- 5 weeks ago - CollPlant Biotechnologies Registration statement: Registration filing - Filings
- 6 weeks ago - CollPlant announces $2.6M private placement - TheFly
- 6 weeks ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT - PRNewsWire
- 2 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 2 months ago - CollPlant Biotechnologies Earnings release: Q1 2026 - Filings
- 4 months ago - CollPlant Biotechnologies Registration statement: Registration filing - Filings
- 4 months ago - CollPlant Issues Letter to Shareholders - PRNewsWire
- 4 months ago - CollPlant files to sell 3.3M ordinary shares for holders - TheFly